EBIT: Income before interest and taxes.
Intensity Therapeutics Inc. (INTS) had EBIT of $-16.59M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-16.27M |
|
-- |
|
-- |
|
$16.59M |
|
$-16.59M |
|
$0.32M |
|
$-16.27M |
|
$-16.27M |
|
$-16.27M |
|
$-16.27M |
|
$-16.27M |
|
$-16.27M |
|
|
EBIT |
$-16.59M |
$-16.56M |
|
13.91M |
|
13.91M |
|
$-1.17 |
|
$-1.17 |
|
| Balance Sheet Financials | |
$3.36M |
|
-- |
|
$1.42M |
|
$4.78M |
|
$1.75M |
|
$0.11M |
|
$0.11M |
|
$1.86M |
|
$2.92M |
|
$2.92M |
|
$2.92M |
|
15.12M |
|
| Cash Flow Statement Financials | |
$-15.22M |
|
$6.35M |
|
$2.90M |
|
$8.56M |
|
$2.59M |
|
$-5.97M |
|
$3.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.92 |
|
-- |
|
-- |
|
0.04 |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-557.51% |
|
-557.51% |
|
-340.12% |
|
-537.25% |
|
$0.19 |
|
$-1.09 |
|
$-1.09 |
|